about
Deep brain stimulation of the periaqueductal gray releases endogenous opioids in humans.The role of in vivo molecular imaging with PET and SPECT in the elucidation of psychiatric drug action and new drug development.Brain serotonin transporter occupancy by oral sibutramine dosed to steady state: a PET study using (11)C-DASB in healthy humans.Sustained recreational use of ecstasy is associated with altered pre and postsynaptic markers of serotonin transmission in neocortical areas: a PET study with [¹¹C]DASB and [¹¹C]MDL 100907Neuroreceptor imaging in psychiatry: theory and applications.Managing inadequate antidepressant response in depressive illness.In vivo imaging of brain microglial activity in antipsychotic-free and medicated schizophrenia: a [(11)C](R)-PK11195 positron emission tomography study.Rapid tryptophan depletion improves decision-making cognition in healthy humans without affecting reversal learning or set shifting.11C-GR103545, a radiotracer for imaging kappa-opioid receptors in vivo with PET: synthesis and evaluation in baboons.In vivo affinity of [18F]fallypride for striatal and extrastriatal dopamine D2 receptors in nonhuman primates.Comparative evaluation of serotonin transporter radioligands 11C-DASB and 11C-McN 5652 in healthy humans.Effect of amphetamine on [(18)F]fallypride in vivo binding to D(2) receptors in striatal and extrastriatal regions of the primate brain: Single bolus and bolus plus constant infusion studies.Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652.Anterior cingulate and subgenual prefrontal blood flow changes following tryptophan depletion in healthy males.Elevated Translocator Protein in Anterior Cingulate in Major Depression and a Role for Inflammation in Suicidal Thinking: A Positron Emission Tomography Study.Acute and chronic changes in brain activity with deep brain stimulation for refractory depression.Pre- and postsynaptic serotonergic differences in males with extreme levels of impulsive aggression without callous unemotional traits: a positron emission tomography study using (11)C-DASB and (11)C-MDL100907.Brain inflammation and psoriasis: a [11 C]-(R)-PK11195 positron emission tomography study.Cerebral serotonin transporter measurements with [11C]DASB: A review on acquisition and preprocessing across 21 PET centres.Microglial activation, white matter tract damage, and disability in MS.Multiple-therapy-resistant major depressive disorder: a clinically important conceptSerotonergic abnormalities in males with extreme levels of impulsive aggression, investigated using 11C-DASB and 11C-MDL100907 PETTreatment-resistant and Multi-therapy resistant criteria for bipolar depression: A consensus definition – CORRIGENDUMTreatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definitionMedication nonadherence in bipolar disorder: a narrative reviewPostnatal depression. Biology mustn't be excludedGuidelines for the content and format of PET brain data in publications and archives: A consensus paperPsoriasis and Mental Health Workshop Report: Exploring the Links between Psychosocial Factors, Psoriasis, Neuroinflammation and Cardiovascular Disease RiskEvidence-based guidelines for the pharmacological treatment of schizophrenia: Updated recommendations from the British Association for PsychopharmacologyRecognition of depression and anxiety in primary care. General health questionnaire alone is not sufficient for making psychiatric diagnosis
P50
Q30838899-8F9782A1-D7FE-4BF0-BD78-F6202FECD60AQ33962966-548D4258-F1BD-4DFE-B22F-DC912D1D3BBFQ34661571-080586E9-72E8-497D-AD55-8E6A2AFE67C5Q35892741-2266FBB0-C418-4F33-B059-8BE3DB40AD95Q36314030-ECE4F813-7DD1-4A46-B422-0A49F8C802FBQ38574699-0FAACE76-E440-4862-8803-95B47648D0DBQ39326557-2A22FB88-7994-4A6C-8BE7-8EEB3B09F970Q40368530-1527E3B3-682E-4BA9-8E07-D83DF47A8DC0Q44348274-21B4B765-7ED5-458A-9A6E-328AF2309BE5Q44801609-B9C349AC-EF7C-49C3-8779-B94B008FA376Q44836739-934769BE-B110-4CC8-AFDC-02226BFFB32FQ45011142-213C16AC-3653-4995-9A82-443A3DC3825FQ46465939-0C805FFD-E3C5-4635-934C-F193C296AE32Q46890920-2ED17F2F-2294-4B6E-8988-2C618A6C71BBQ47616159-5D7C3C3C-4F7E-4FE2-952F-380D3D0E1F24Q47681552-055AEC90-40FA-40FB-BB6D-F6B83657BBA1Q48427795-4CEB0869-4EA4-4233-AA1C-C6ACF60FB995Q48455654-06A798C8-F239-4FCA-B898-7B52933B5FDFQ52322702-588F9F06-BCA0-493E-A16A-83A2744DC059Q54379389-1BF51ED7-73DF-476A-A7E3-8B3CF29F3872Q60636590-6A8F9CC5-7FBE-4A11-940B-9E50A96C5835Q60708292-C2BC5135-3CD7-46AB-B573-C86F3D1F7D19Q62675750-43F77150-C467-4A09-AD5F-70FF72915424Q62675773-E38BD195-4891-4095-A0E3-7526014E91F7Q64321080-9585FBA7-37A2-4830-A2F2-D1457C707252Q77900775-2B85B225-E439-4159-AE6D-15B34CB73A2BQ89741073-A9A71B25-AC2F-4025-9541-13DF6CDAAD6DQ91336363-D1AD73CF-BD0D-4D0F-B1C5-0DF1A9A07A21Q91914835-8BDB1533-507A-4102-9548-9D8FBD365CAAQ95809603-1D575024-B652-4F72-8600-C5592E4BCDBD
P50
description
researcher ORCID ID = 0000-0003-3492-0801
@en
wetenschapper
@nl
name
Peter S Talbot
@ast
Peter S Talbot
@en
Peter S Talbot
@es
Peter S Talbot
@nl
type
label
Peter S Talbot
@ast
Peter S Talbot
@en
Peter S Talbot
@es
Peter S Talbot
@nl
prefLabel
Peter S Talbot
@ast
Peter S Talbot
@en
Peter S Talbot
@es
Peter S Talbot
@nl
P106
P1153
7102670261
7102670273
P31
P496
0000-0003-3492-0801